Ligand Pharmaceuticals LGND Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfShortTermInvestments.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's investment proceeds?
- Ligand Pharmaceuticals (LGND) reported investment proceeds of $1.3M in Q1 2026.
- How has Ligand Pharmaceuticals's investment proceeds changed year-over-year?
- Ligand Pharmaceuticals's investment proceeds decreased by 96.6% year-over-year, from $38.41M to $1.3M.
- What is the long-term trend for Ligand Pharmaceuticals's investment proceeds?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's investment proceeds has grown at a 0.9% compound annual growth rate (CAGR), from $154.23M to $159.58M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.